• Health & Medicine

Fears breast cancer progress could stall due to COVID-19 backlog

Around 10,600 fewer breast cancer patients have started treatment in the last year in England, as experts fear hard-won progress could slow. Around 10,600 fewer breast cancer patients have started treatment in the last year in England, as experts fear hard-won progress could slow.

15 June 2021

• Science & Technology
• Health & Medicine

ASCO 2021 news: follow-up treatments pave the way

One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented. One of the biggest meetings of the world’s cancer specialists took place this weekend. Here’s a flavour of the some of the top research presented.

9 June 2021

• Health & Medicine
• For Supporters

Professor Ian Tomlinson: “Philanthropy is priceless to science”

The director of our Cancer Research UK Edinburgh Centre walks us through some of his proudest research achievements and how supporters have made them possible. The director of our Cancer Research UK Edinburgh Centre walks us through some of his proudest research achievements and how supporters have made them possible.

3 June 2021

• For Researchers

A bug in the system – the difficulties of linking the microbiome to cancer aetiology

Teasing apart causation from correlation is vital if we are to understand whether the gut microbiome changes the risk of cancer or whether cancer changes the gut microbiome. Teasing apart causation from correlation is vital if we are to understand whether the gut microbiome changes the risk of cancer or whether cancer changes the gut microbiome.

2 June 2021

• Science & Technology

Scientists find cells in centre of tumours are most likely to spread

The new findings shed light on how cancer cells found in different parts of a tumour behave differently. The new findings shed light on how cancer cells found in different parts of a tumour behave differently.

19 May 2021

• Health & Medicine

Cancer Research UK spin-out goes public, ready to invest more in precision T cell therapies

Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO). Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO).

18 May 2021

• Health & Medicine

Ovarian cancer screening trial did not save lives

In 1999, Menon joined Professor Ian Jacobs to set up the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). 20 years later, the results are in. In 1999, Menon joined Professor Ian Jacobs to set up the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). 20 years later, the results are in.

12 May 2021

• Science & Technology

‘Never done before’ AI study could improve early detection of pancreatic cancer

Around 8 in 10 pancreatic cancer cases are currently diagnosed late in England and Wales. Around 8 in 10 pancreatic cancer cases are currently diagnosed late in England and Wales.

7 May 2021

• Science & Technology

Stressed out – the cancer cells that survive chemotherapy, but at a cost

A group of Cancer Research UK-funded scientists are beginning to discover new vulnerabilities in cancer cells, which emerge when they enter ‘survival mode’. A group of Cancer Research UK-funded scientists are beginning to discover new vulnerabilities in cancer cells, which emerge when they enter ‘survival mode’.

29 April 2021

• Science & Technology

New method analyses DNA changes with ‘unprecedented accuracy’

Using the technology, scientists have revealed that cell division isn’t necessarily the main cause of genetic changes in human tissue DNA. Using the technology, scientists have revealed that cell division isn’t necessarily the main cause of genetic changes in human tissue DNA.

29 April 2021

• Science & Technology

Scientists developing new class of drug for leukaemia

Scientists are developing a new drug for treating acute myeloid leukaemia (AML), a type of blood cancer that affects around 3,100 people in the UK each year.  Scientists are developing a new drug for treating acute myeloid leukaemia (AML), a type of blood cancer that affects around 3,100 people in the UK each year. 

27 April 2021

• Science & Technology

Mutations in overlooked DNA could have profound impact on bowel cancer survival

DNA errors in the cell’s energy ‘factories’ increases the chances of survival for people with bowel cancer, according to a new study. DNA errors in the cell’s energy ‘factories’ increases the chances of survival for people with bowel cancer, according to a new study.

8 April 2021